BDBM716243 N-[2-(1-methyl-2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]-14-({2-methyl-8-[4-(trifluoromethyl)phenyl]-2H,8H-pyrazolo[3,4-b]indol-5-yl}formamido)-3,6,9,12-tetraoxatetradecanamide (Compound 36)::US20250032625, Compound 36

SMILES CN1C(=O)CCC(N2C(=O)c3cccc(NC(=O)COCCOCCOCCOCCNC(=O)c4ccc5c(c4)c4cn(C)nc4n5-c4ccc(C(F)(F)F)cc4)c3C2=O)C1=O

InChI Key InChIKey=JKESGWHCFXQFFI-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 716243   

TargetTranscriptional enhancer factor TEF-1 [209-426](Human)
Merck Patent

US Patent
LigandPNGBDBM716243(N-[2-(1-methyl-2,6-dioxopiperidin-3-yl)-1,3-dioxo-...)
Affinity DataKd:  980nMAssay Description:The kinetic and affinity parameters of protein-exemplary compound interactions were evaluated by SPR. hsTEAD1 (209-426) was immobilized onto a CM7 (S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent